What is NDC 47426-101?

47426-101 is the product NDC for Sustol (granisetron), Granisetron 10 mg/.4mL injection, listed with the FDA by Heron Therapeutics, Inc..

Heron Therapeutics, Inc., NDC labeler code 47426. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sustol?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sustol NDC 47426-101 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)47426-101Labeler and product segments. Claims need a package NDC.

Product NDC at billing width47426-0101Add the package segment from the table below.

Product information

Brand name (proprietary): Sustol
Generic name (nonproprietary): granisetron
Active ingredients: Granisetron — 10 mg/.4mL
Dosage form: Injection
Route: Subcutaneous
Labeler: Heron Therapeutics, Inc.NDC labeler code 47426
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022445
Marketing start: Aug 9, 2016
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 3 Receptor Antagonists (Mechanism)
Identifiers: Product ID 47426-101_7b12942e-ba3d-4921-8418-34dc5a0cb35bSPL ID 7b12942e-ba3d-4921-8418-34dc5a0cb35bSPL set ID f7c7ffdd-8270-4030-bc1e-a1cb28a6de56RxCUI 1810484, 1810489UNII WZG3J2MCOL
Pharmacologic class: Serotonin-3 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

Product label

Current FDA label (SPL), effective Apr 30, 2026.

Indications (excerpt from the label)

SUSTOL is indicated in combination with other antiemetics in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. SUSTOL is a serotonin-3 (5-HT 3 ) receptor antagonist indicated in combination with other antiemetics in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 47426-101

What is NDC 47426-101?: 47426-101 is the product NDC for Sustol (granisetron), Granisetron 10 mg/.4mL injection, listed with the FDA by Heron Therapeutics, Inc..
What drug is associated with this NDC?: Sustol (Granisetron).
What is the active ingredient?: Granisetron.
Who is the labeler?: Heron Therapeutics, Inc., NDC labeler code 47426. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sustol?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Sustol (Granisetron) NDC 47426-101